Home›Companies›Biotech & Pharma›Pluristyx

Pluristyx Inc.

Provides stem cells and development services to cell therapy developers.

Updated Nov 10, 2026·Latest SEC filing Jul 13, 2026·Suggest an edit

About Pluristyx

Pluristyx is a private company based in Seattle, Washington. It has reported $9,757,789 raised in one offering on Form D since July 2026. Its chief executive is Benjamin Fryer.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 1, 2026Jul 13, 2026$9,757,789of $14.7M target13$750KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Pluristyx's Form D filed Jul 13, 2026.

BF
Benjamin Fryer
Chief Executive Officer and director
Jason Carstens
Jason Carstens
Chief Operating Officer and director
TC

Sources

  1. SECPluristyx Inc. filing history
  2. CompanyAbout Pluristyx
  3. CompanyManagement team